Monopar Therapeutics Inc. (MNPR)

Monopar Therapeutics Statistics

Total Valuation

MNPR has a market cap or net worth of $575.91 million. The enterprise value is $432.33 million.

Market Cap	575.91M
Enterprise Value	432.33M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MNPR has 6.68 million shares outstanding. The number of shares has increased by 97.28% in one year.

Current Share Class	6.68M
Shares Outstanding	6.68M
Shares Change (YoY)	+97.28%
Shares Change (QoQ)	+1.80%
Owned by Insiders (%)	4.87%
Owned by Institutions (%)	47.39%
Float	3.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.06
P/TBV Ratio	4.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 56.10, with a Debt / Equity ratio of 0.00.

Current Ratio	56.10
Quick Ratio	55.94
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.54% and return on invested capital (ROIC) is -18.44%.

Return on Equity (ROE)	-26.54%
Return on Assets (ROA)	-17.99%
Return on Invested Capital (ROIC)	-18.44%
Return on Capital Employed (ROCE)	-15.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +316.33% in the last 52 weeks. The beta is 1.47, so MNPR's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	+316.33%
50-Day Moving Average	84.10
200-Day Moving Average	49.42
Relative Strength Index (RSI)	53.38
Average Volume (20 Days)	160,697

Short Selling Information

The latest short interest is 371,120, so 5.55% of the outstanding shares have been sold short.

Short Interest	371,120
Short Previous Month	256,778
Short % of Shares Out	5.55%
Short % of Float	9.48%
Short Ratio (days to cover)	2.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.62M
Pretax Income	-19.44M
Net Income	-19.44M
EBITDA	n/a
EBIT	-21.62M
Earnings Per Share (EPS)	-$2.99

Balance Sheet

The company has $143.68 million in cash and $102,236 in debt, giving a net cash position of $143.57 million or $21.48 per share.

Cash & Cash Equivalents	143.68M
Total Debt	102,236
Net Cash	143.57M
Net Cash Per Share	$21.48
Equity (Book Value)	141.56M
Book Value Per Share	21.25
Working Capital	141.52M

Cash Flow

Operating Cash Flow	-10.83M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.28%
Shareholder Yield	-97.28%
Earnings Yield	-3.38%
FCF Yield	n/a

Analyst Forecast

The average price target for MNPR is $97.83, which is 13.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$97.83
Price Target Difference	13.52%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 13, 2024. It was a reverse split with a ratio of 1:5.

Last Split Date	Aug 13, 2024
Split Type	Reverse
Split Ratio	1:5

Scores

Altman Z-Score	n/a
Piotroski F-Score	2